Haematologica, Vol 89, Issue 5, 621-622
Copyright © 2004 by Ferrata Storti Foundation
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia
F Ferrara,
S Palmieri,
M Annunziata,
B Pocali,
A Viola,
and
F Pane
Six patients with relapsed acute promyelocytic leukemia (APL) received autologous stem cell transplantation (ASCT) in second (n=5) or fourth (n=1) molecular remission with a molecularly negative graft. After a median follow-up of 33 months from ASCT, 5 patients are alive in molecular remission and one died 27 months after autograft from refractory relapse.